Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer

Oncogene volume 21, pages 5097–5107 (2002)Cite this article

Abstract

BRCA1 mutation carriers have an increased susceptibility to breast and ovarian cancer. Excision of exon 11 of Brca1 in the mouse, using a conditional knockout (Cre-loxP) approach, results in mammary tumor formation after long latency. To characterize the genomic instability observed in these tumors, to establish a comparative map of chromosomal imbalances and to contribute to the validation of this mouse model of breast cancer, we have characterized chromosomal imbalances and aberrations using comparative genomic hybridization (CGH), and spectral karyotyping (SKY). We found that all tumors exhibit chromosome instability as evidenced by structural chromosomal aberrations and aneuploidy, yet they display a pattern of chromosomal gain and loss that is similar to the pattern in human breast carcinomas. Of note, nine of 15 tumors exhibited a gain of distal chromosome 11, a region that is orthologous to human chromosome 17q11-qter, the mapping position of Erbb2. However, our analysis suggests that genes distal to Erbb2 are the main targets of amplification. Four of the tumors also exhibited a copy number loss of proximal chromosome 11 (11A-B), a region orthologous to human 17p. In eight of the tumors we observed whole or partial gain of chromosome 15 centering on 15D2-D3 (orthologous to human chromosome 8q24), the map location of the c-Myc gene, and six of the tumors exhibited copy number loss of whole or partial chromosome 14, including 14D3, the map location of Rb1. We conclude that despite the tremendous shuffling of chromosomes during the course of mammalian evolution, the pattern of genomic imbalances is conserved between BRCA1-associated mammary gland tumors in mice and humans. Western blot analysis showed that while p53 is absent or mutated in some tumors, at least two tumors revealed wild-type protein, suggesting that other genetic events may lead to tumorigenesis. Similar to BRCA1-deficient mouse embryonic fibroblasts, the tumor cells contained supernumerary functional centrosomes with intact centrioles whose presence results in multipolar mitoses and aneuploidy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bacon CM, Tortolani PJ, Shimosaka A, Rees RC, Longo DL, O'Shea JJ . 1995 FEBS Lett. 370: 63–68

  • Barlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O, Kallioniemi A . 1997 Genes Chromosomes Cancer 20: 372–376

  • Bieche I, Lidereau R . 1995 Genes Chromosomes Cancer 14: 227–251

  • Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R . 2000 Cell 102: 257–265

  • Deng CX, Brodie SG . 2001 Semin. Cancer Biol. 11: 387–394

  • Deng CX, Scott F . 2000 Oncogene 19: 1059–1064

  • Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T . 1999 Am. J. Pathol. 154: 525–536

  • Gowen LC, Johnson BL, Latour AM, Sulik KK, Kollar BH . 1996 Nat. Genet. 12: 191–194

  • Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW . 1996 Cell 85: 1009–1023

  • Hsu L-C, White RL . 1998 Proc. Natl. Acad. Sci. USA 95: 12983–12988

  • Khanna KK, Jackson SP . 2001 Nat. Genet. 27: 247–254

  • Liu CY, Flesken-Nikitin A, Li S, Zeng Y, Lee WH . 1996 Genes Dev. 10: 1835–1843

  • Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, Barlow C, Wynshaw-Boris A, Janz S, Wienberg J, Ferguson-Smith MA, Schrock E, Ried T . 1996 Nat. Genet. 14: 312–315

  • Ludwig T, Chapman DL, Papaioannou VE, Efstratiadis A . 1997 Genes Dev. 11: 1226–1241

  • Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML, Kallioniemi A . 2001 Proc. Natl. Acad. Sci. USA 98: 5711–5716

  • Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ, Ried T . 2002 Oncogene 21: 890–898

  • Nass SJ, Dickson RB . 1997 Breast Cancer Res. Treat. 44: 1–22

  • Phillips JL, Hayward SW, Wang Y, Vasselli J, Pavlovich C, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T . 2001 Cancer Res. 61: 8143–8149

  • Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, Nosrati A, Willson JK, Mack D, Ried T, Markowitz S . 2002 Cancer Res. 62: 1134–1138

  • Rhei E, Bogomolniy F, Federici MG, Maresco DL, Offit K, Robson ME, Saigo PE, Boyd J . 1998 Cancer Res. 58: 3193–3196

  • Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G . 1999 Genes Chromosomes Cancer 25: 195–204

  • Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T, Auer G . 1995 Cancer Res. 55: 5415–5423

  • Schuyer M, Berns EM . 1999 Mol. Cell Endocrinol. 155: 143–152

  • Schuyer M, Henzen-Logmans SC, van der Burg ME, Fieret JH, Derksen C, Look MP, Meijer-van Gelder ME, Klijn JG, Foekens JA, Berns EM . 1999 Eur. J. Obstet. Gynecol. Reprod. Biol. 82: 147–150

  • Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, Ried T, Deng CX . 1998 Oncogene 17: 3115–3124

  • Spector DL, Goldman RD, Leinwand LA . 1997 Cells: A Laboratory Manual. Cold Spring Harbor Laboratory Press

    Google Scholar 

  • Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallioniemi OP . 1997 Cancer Res. 57: 1222–1227

  • Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF . 1998 Cancer Res. 58: 3237–3242

  • Vaziri SA, Tubbs RR, Darlington G, Casey G . 2001 Mol. Pathol. 54: 259–263

  • Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schrock E, Dickson RB, Ried T . 1999 Genes Chromosomes Cancer 25: 251–260

  • Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ . 2000 Cancer Res. 60: 5371–5375

  • Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX . 2001 Nat. Genet. 28: 266–271

  • Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX . 1999a Nat. Genet. 22: 37–43

  • Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX . 1999b Mol. Cell. 3: 389–395

  • Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH . 1999 Science 285: 747–750

Download references

Acknowledgements

The authors wish to thank Buddy Chen for manuscript editing, Joseph Cheng for IT-support and David L Spector for helpful discussions.

Author information

Author notes

  1. Zoë Weaver

    Present address: Avalon Pharmaceuticals, 19 Firstfield Road, Gaithersburg, 20878, Maryland, MD, USA

Authors and Affiliations

  1. Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH, Bethesda, Maryland, USA

    Zoë Weaver, Cristina Montagna & Thomas Ried

  2. Genetics of Development and Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases/NIH, Bethesda, Maryland, USA

    Xiaoling Xu, Steven G Brodie & Chu-Xia Deng

  3. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA

    Tamara Howard

  4. National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland, USA

    Massimo Gadina

Authors
  1. Zoë Weaver
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Montagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoling Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tamara Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Massimo Gadina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven G Brodie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chu-Xia Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Thomas Ried
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Ried.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weaver, Z., Montagna, C., Xu, X. et al. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 21, 5097–5107 (2002). https://doi.org/10.1038/sj.onc.1205636

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205636

Keywords

This article is cited by

Search

Advanced search

Quick links